@MarkC53916729 @RVH_Investing RVH_Investing a LOOSER, as loosing out not being long $ARWR, not taking time to reflect publicly about the science, their data, it’s accomplishments. Arrowhead Pharma has most advanced-to-date programs on HBV (now part of $JNJ) and AAT. Moving into new indications, will expand it